ACCESSION: MSBNK-SMB_Measured-HSA001P0153004
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 75
COMMENT: RAW_SPEC {'12_posi_7234': {'bp': 140136.0, 'sum': 269714.0}, '2_posi_7257': {'bp': 138194.0, 'sum': 278680.0}, '16_posi_7783': {'bp': 137575.0, 'sum': 289079.0}, '10_posi_7362': {'bp': 137556.0, 'sum': 278972.0}, '19_posi_7239': {'bp': 137278.0, 'sum': 283859.0}, '2_posi_7111': {'bp': 137093.0, 'sum': 275881.0}, '13_posi_7592': {'bp': 137008.0, 'sum': 287509.0}, 'BLK02_7324': {'bp': 136948.0, 'sum': 291853.0}, 'BLK02_7106': {'bp': 136502.0, 'sum': 296182.0}, '1_posi_7152': {'bp': 136271.0, 'sum': 295561.0}, '15_posi_7106': {'bp': 135526.0, 'sum': 266473.0}, '19_posi_7426': {'bp': 135160.0, 'sum': 296930.0}, '17_posi_7133': {'bp': 135093.0, 'sum': 276682.0}, '17_posi_7529': {'bp': 134896.0, 'sum': 271653.0}, '17_posi_7277': {'bp': 133252.0, 'sum': 288273.0}, '18_posi_7107': {'bp': 132846.0, 'sum': 309451.0}, '12_posi_7827': {'bp': 132256.0, 'sum': 278290.0}, '19_posi_7340': {'bp': 132132.0, 'sum': 287460.0}, '13_posi_7782': {'bp': 131914.0, 'sum': 275184.0}, '16_posi_7617': {'bp': 130818.0, 'sum': 245877.0}, '18_posi_7721': {'bp': 130686.0, 'sum': 284724.0}, '19_posi_7509': {'bp': 130374.0, 'sum': 294690.0}, '18_posi_7637': {'bp': 130038.0, 'sum': 252814.0}, '6_posi_7235': {'bp': 129540.0, 'sum': 264944.0}, '10_posi_7133': {'bp': 128753.0, 'sum': 269025.0}, 'BLK02_7406': {'bp': 128693.0, 'sum': 296524.0}, '9_posi_7191': {'bp': 128252.0, 'sum': 250325.0}, '13_posi_7511': {'bp': 128094.0, 'sum': 282535.0}, '17_posi_7362': {'bp': 127938.0, 'sum': 260958.0}, '11_posi_7254': {'bp': 126384.0, 'sum': 260672.0}, '19_posi_7170': {'bp': 125674.0, 'sum': 258494.0}, '18_posi_7489': {'bp': 125562.0, 'sum': 254620.0}, 'ProcedureBlank_7318': {'bp': 124588.0, 'sum': 260915.0}, '14_posi_7552': {'bp': 123963.0, 'sum': 248677.0}, '18_posi_7211': {'bp': 123766.0, 'sum': 253810.0}, '17_posi_7783': {'bp': 123431.0, 'sum': 270392.0}, '14_posi_7105': {'bp': 123279.0, 'sum': 277497.0}, '8_posi_7364': {'bp': 122050.0, 'sum': 242543.0}, '11_posi_7380': {'bp': 122024.0, 'sum': 265533.0}, '14_posi_7340': {'bp': 122014.0, 'sum': 257561.0}, '1_posi_7474': {'bp': 122010.0, 'sum': 244722.0}, 'ProcedureBlank_7592': {'bp': 121660.0, 'sum': 284623.0}, 'ProcedureBlank_7426': {'bp': 121551.0, 'sum': 266744.0}, '15_posi_7361': {'bp': 120634.0, 'sum': 267846.0}, '19_posi_7694': {'bp': 120339.0, 'sum': 265844.0}, '4_posi_7255': {'bp': 120083.0, 'sum': 258193.0}, '8_posi_7574': {'bp': 119904.0, 'sum': 257466.0}, '17_posi_7594': {'bp': 118924.0, 'sum': 250572.0}, '13_posi_7653': {'bp': 118897.0, 'sum': 251587.0}, '13_posi_7429': {'bp': 118420.0, 'sum': 260896.0}, '11_posi_7616': {'bp': 118296.0, 'sum': 254508.0}, '7_posi_7429': {'bp': 118038.0, 'sum': 271587.0}, '16_posi_7318': {'bp': 117971.0, 'sum': 262884.0}, 'BLK02_7574': {'bp': 117302.0, 'sum': 292358.0}, '3_posi_7510': {'bp': 117124.0, 'sum': 263717.0}, '1_posi_7300': {'bp': 116836.0, 'sum': 264414.0}, 'ProcedureBlank_7655': {'bp': 116284.0, 'sum': 251885.0}, '4_posi_7318': {'bp': 113862.0, 'sum': 241789.0}, '12_posi_7595': {'bp': 113480.0, 'sum': 258667.0}, '15_posi_7613': {'bp': 113069.0, 'sum': 248656.0}, '17_posi_7700': {'bp': 111691.0, 'sum': 236946.0}, '19_posi_7613': {'bp': 111399.0, 'sum': 244051.0}, '10_posi_7549': {'bp': 111339.0, 'sum': 252605.0}, '15_posi_7782': {'bp': 110774.0, 'sum': 252258.0}, '11_posi_7760': {'bp': 109767.0, 'sum': 222910.0}, '5_posi_7845': {'bp': 109570.0, 'sum': 248119.0}, 'BLK02_7735': {'bp': 109306.0, 'sum': 261362.0}, '7_posi_7546': {'bp': 109292.0, 'sum': 240542.0}, '9_posi_7594': {'bp': 108413.0, 'sum': 213339.0}, 'BLK02_7828': {'bp': 106764.0, 'sum': 234664.0}, '1_posi_7723': {'bp': 104127.0, 'sum': 240944.0}, '2_posi_7405': {'bp': 102795.0, 'sum': 222175.0}, '6_posi_7615': {'bp': 101574.0, 'sum': 235904.0}, '9_posi_7826': {'bp': 100626.0, 'sum': 217759.0}, '7_posi_7741': {'bp': 97586.0, 'sum': 242544.0}}
COMMENT: RETENTION_TIME_STDEV 0.436
COMMENT: PRECURSOR_M/Z_RAW 153.113083
COMMENT: PRECURSOR_M/Z_STDEV 0.000050
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.322; C7H12N4; [M+H]+; delta(ppm) -0.322143
COMMENT: PROPOSED_MF MS-FINDER 2.464; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.399; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_MF SIRIUS5_Sirius -2.431; C9H14NO; [M+H]+; delta(ppm) -9.094534
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.373; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.556; C4H13FN4O; [M+H]+; delta(ppm) -7.788272
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.764; C9H14NO; [M+H]+; delta(ppm) -9.094534
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.094; C3H15N5P; [M+H]+; delta(ppm) -2.344318
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.325538
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.917; KYAGGLONXREQED-UHFFFAOYSA-N; [M+H]+; 3-ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.741; RWSWNQOCJVPCMF-UHFFFAOYSA-N; [M+H]+; 5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.490; RMTCWOLYVMOKBR-UHFFFAOYSA-N; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.449; SAYXVILDUZLWGX-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.230; FHYDQGOVTLQZSZ-UHFFFAOYSA-N; [M+H]+; N'-pyrimidin-2-ylpropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.189; MHMOUFDAKNJXSK-UHFFFAOYSA-N; [M+H]+; 1-(1H-imidazol-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.104; KFJYLCFNRATSPE-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.025; ASGQRNXDYZQNPS-UHFFFAOYSA-N; [M+H]+; 4-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; DAAKLDCBWHWWNI-RMKNXTFCSA-N; [M+H]+; N-methyl-N-[(E)-(1-methylimidazol-2-yl)methylideneamino]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.879; QDEKQIPSPLAOPI-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.862; SANLPMMCLNQJPP-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-5-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.837; OQHDZWPNEOFLCW-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.827; FILWPDPGRBPZDL-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.816; YPPVPNFMCXRUCC-UHFFFAOYSA-N; [M+H]+; 4-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.804; GMVWRTAXMQPIBG-UHFFFAOYSA-N; [M+H]+; 5-(1-aminoethyl)-4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.787; QFOSWZIUPHQBRK-UHFFFAOYSA-N; [M+H]+; 8-methyl-2,3,6,7-tetrahydroimidazo[1,2-a]pyrimidin-5-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.755; KHDBXRADZIIFBK-UHFFFAOYSA-N; [M+H]+; 2-(1-cyclopropyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.752; GFUMZGPBCAJZHH-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyltriazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.746; IMQGJTWGILNPMZ-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.742; JBICIOACIKMMJM-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-N,N-dimethylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.739; GESFEOZCDXMGFO-UHFFFAOYSA-N; [M+H]+; 2-(6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.738; MSQSNZKVWZTSDJ-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.728; JUYYERAJUGNAKT-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1,2,4-triazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.727; DLVUEWDMHXYYAO-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.700; WJXSFSALUZCCJQ-UHFFFAOYSA-N; [M+H]+; 3,8-dimethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.689; IFPQNVUJBNWAGL-UHFFFAOYSA-N; [M+H]+; 2-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.676; ZEFRABOWIHXNKA-UHFFFAOYSA-N; [M+H]+; 3-methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-d][1,4]diazepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.666; XNHWFJRPVBJRPR-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.654; LGIWBPLJDKOQSX-UHFFFAOYSA-N; [M+H]+; 4-(2H-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.650; KGXBEJFERUBKKY-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.646; KNGLSUWCXOCEKZ-UHFFFAOYSA-N; [M+H]+; 3-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.645; FYKDYYGNYLGWCA-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.642; KLDLJJRSWZYEFL-UHFFFAOYSA-N; [M+H]+; 6,6-dimethyl-4,5-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.639; MJIWVLBPVFCYJB-ZETCQYMHSA-N; [M+H]+; 1-[[(2S)-pyrrolidin-2-yl]methyl]triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.636; OIZMGVQEOVIMOL-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-pyrrolidin-3-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.634; KGLMRCGIKAKFCH-UHFFFAOYSA-N; [M+H]+; 3-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.633; URSHNSSBVLGWNY-UHFFFAOYSA-N; [M+H]+; 1-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.633; YRQUFBNVMMTCEX-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.633; UOGYOJNDIFVZLJ-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.633; QCAHQEGOYONBHI-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.633; NMHSRADHFBXGAG-UHFFFAOYSA-N; [M+H]+; 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.631; XMNCTKKZAFGKBV-UHFFFAOYSA-N; [M+H]+; 5-pyrrolidin-3-yl-1H-pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.628; BXSGLNRNBMUCIM-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.626; AGIXGQFDUZRXCT-UHFFFAOYSA-N; [M+H]+; 1-(pyrrolidin-2-ylmethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.625; GREJTVKJTDGUQI-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.624; FNMXKIOFMCGDMH-UHFFFAOYSA-N; [M+H]+; (5-cyclopropyl-2-methyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.622; XDUNSNMMXUKPIN-ZCFIWIBFSA-N; [M+H]+; 4-methyl-3-[(2R)-pyrrolidin-2-yl]-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.622; NYWMQSMKGVCQED-LURJTMIESA-N; [M+H]+; 3-methyl-5-[(2S)-pyrrolidin-2-yl]-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.622; KELKBKXPSNKQRJ-UHFFFAOYSA-N; [M+H]+; [1-(cyclopropylmethyl)triazol-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.615; HSBDIERXOJWHKI-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.613; IZHAMQUVVWJULL-UHFFFAOYSA-N; [M+H]+; 3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.604; COBJBBVQXYDCJU-UHFFFAOYSA-N; [M+H]+; N-[(1-methyltriazol-4-yl)methyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.604; PWQFWTMOGJDMLO-UHFFFAOYSA-N; [M+H]+; [3-(1,2,4-triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.586; NNTDOOSCXNZOBK-UHFFFAOYSA-N; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.573; PWEGFMVXXGYUTH-UHFFFAOYSA-N; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.570; DKRJNDYSGMPAAB-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.550; OEURBUBEWIXBKU-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.507; VFXLTLDREFAZCG-UHFFFAOYSA-N; [M+H]+; [3-(triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.248; HWXAKUICDBKUDB-UHFFFAOYSA-N; [M+H]+; 4-azidobicyclo[2.2.1]heptan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -150.410; RMTCWOLYVMOKBR; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.388; PWEGFMVXXGYUTH; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.567; RWSWNQOCJVPCMF; [M+H]+; 5-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.462; COBJBBVQXYDCJU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.228; DKRJNDYSGMPAAB; [M+H]+; 1,2,4-triazolo[4,5-a]piperidin-3-ylmethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.583; NNTDOOSCXNZOBK; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.103; RMTCWOLYVMOKBR; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -124.742; DKRJNDYSGMPAAB; [M+H]+; (5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-A]pyridin-3-YL)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.546; RWSWNQOCJVPCMF; [M+H]+; 5-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -144.823; QDEKQIPSPLAOPI; [M+H]+; 2-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -154.739; FHYDQGOVTLQZSZ; [M+H]+; N-(3-aminopropyl)pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -154.921; COBJBBVQXYDCJU; [M+H]+; N-((1-methyl-1H-1,2,3-triazol-4-yl)methyl)cyclopropanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.998; YRQUFBNVMMTCEX; [M+H]+; 3-methyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.118; YPPVPNFMCXRUCC; [M+H]+; 4-(4H-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.321; XNHWFJRPVBJRPR; [M+H]+; 3-methyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -175.175; IZHAMQUVVWJULL; [M+H]+; (3R)-3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -175.211; FYKDYYGNYLGWCA; [M+H]+; (6R)-2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.138; DKRJNDYSGMPAAB; [M+H]+; (5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-A]pyridin-3-YL)methanamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H13N4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 14.977
MS$FOCUSED_ION: PRECURSOR_M/Z 153.113423
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-2900000000-dd31a4dc76b4d311a3d9
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0445944 37.5597 69.045220 1.7090 8.86 0.3403 67 f{C3H5N2}/-1.89ppm,p-C4H8N2
  71.0603868 253.5941 71.061000 0.5488 26.67 0.5197 75 f{C3H7N2}/0.17ppm,p-C4H6N2
  83.0601763 87.8162 83.060680 1.3003 16.22 0.3708 75 f{C4H7N2}/-2.39ppm,p-C3H6N2
  85.0758207 78.1585 85.076300 1.3165 16.34 0.4692 74 f{C4H9N2}/-2.40ppm,p-C3H4N2
  110.0713135 167.0180 110.071540 1.0902 21.70 0.5022 75 f{C5H8N3}/0.36ppm,p-C2H5N1
  124.0867849 39.8219 124.086840 2.5466 11.10 -0.0634 67 f{C6H10N3}/-1.12ppm,p-C1H3N1
  126.1024232 53.6638 126.102450 2.0460 11.34 0.1916 75 f{C6H12N3}/-1.19ppm,p-C1H1N1
  153.0655442 42.2115 153.065440 2.0122 9.67 -0.0210 59 ?
  153.0769042 56.3470 153.076800 1.8945 13.67 -0.0234 73 ?
  153.1025842 79.8390 153.102480 1.3912 14.55 0.0961 75 ?
  153.1132442 999.0000 153.113140 0.4506 0.00 1.0000 75 f{C7H13N4}/-1.49ppm,p
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  69.044594 37.56 37
  71.060387 253.59 253
  83.060176 87.82 87
  85.075821 78.16 78
  110.071313 167.02 167
  124.086785 39.82 39
  126.102423 53.66 53
  153.065544 42.21 42
  153.076904 56.35 56
  153.102584 79.84 79
  153.113244 999.00 999
//
